Skip to main content
Fig. 2 | Cardio-Oncology

Fig. 2

From: A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene)

Fig. 2

Comparison of PCI for a patient on Targretin therapy complicated by elevated triglycerides. a PCI required on May 31, 2016: the proximal segment of the RCA indicates prior stent placement in 2006 with 0% residual occlusion. The distal segment shows 50% occlusion. The LAD shows a 50% occlusion in the proximal segment. The Obtuse Marginal 1 segment is 95% occluded. A DES was placed resulting in 0% residual occlusion. The Obtuse Marginal 2 has 40% occlusion. b PCI required 8 weeks later on July 29, 2016: the LAD shows 95% occlusion in the proximal segment, in which a DES was placed; the result was 0% occlusion. The distal segment of the RCA indicates a reduction from 50 to 30%. The OM2 diameter was not measured in the second study

Back to article page